Takeda Pharmaceutical
314 hedge funds and large institutions have $1.97B invested in Takeda Pharmaceutical in 2021 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 107 increasing their positions, 70 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
314
Holders Change
+4
Holders Change %
+1.29%
% of All Funds
5.53%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
56
Increased
107
Reduced
70
Closed
49
Calls
$95.8M
Puts
$89.6M
Net Calls
+$6.19M
Net Calls Change
+$12M
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$184M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$34M |
| 3 |
BlackRock
New York
|
+$25M |
| 4 |
GCM
Glenview Capital Management
New York
|
+$15.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$13.4M |
Top Sellers
| 1 |
AC
Adelphi Capital
London,
United Kingdom
|
-$138M |
| 2 |
PC
Paulson & Co
New York
|
-$120M |
| 3 |
Renaissance Technologies
New York
|
-$39.2M |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
-$15.6M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$14.3M |
